The Resilient Growth of Longevity and Anti-Senescence Therapies | $44.2 Billion by 2030

The Longevity and Anti-senescence Therapy Market is a rapidly growing sector dedicated to extending human lifespan and improving the quality of life in aging populations. The market encompasses a wide array of innovative therapies, interventions, and products designed to combat the effects of aging at the cellular and molecular levels. The longevity and anti-senescence therapy market size was valued at $25.1 billion in 2020, and is estimated to reach $44.2 billion by 2030, growing at a CAGR of 6.1% from 2021 to 2030.

♦ 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 -
https://www.alliedmarketresearch.com/request-sample/14379

From regenerative medicine and gene therapies to senolytics and lifestyle interventions, researchers and biotech companies are exploring groundbreaking approaches to delay age-related diseases and promote healthy aging. With an aging global population and an increasing focus on preventive healthcare, the Longevity and Anti-senescence Therapy Market holds tremendous promise for transforming the future of healthcare and revolutionizing the way we age.

Major Key Market Players -

AgeX Therapeutics, Inc.
Bristol-Myers Squibb Company
Calico Life Sciences LLC
CohBar, Inc.
Life Biosciences, Inc.
Merck & Co., Inc.
Oisin Biotechnologies
Pfizer Inc.
T.A. Sciences, Inc.
Unity Biotechnology, Inc.

Based on the treatment regimen, the longevity market is segmented into senolytic drug therapy, gene therapy, and immunotherapy. The gene therapy segment dominates the market in 2020 and is expected to be the dominant player during the forecast period, due to rise in awareness of longevity and vaccines, rise in disease and - not slow and effective product launch.

♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/14379

According to the application, longevity is divided into senescence treatment research such as cancer and others. The cancer segment dominates the market in 2020 and is expected to continue to dominate during the forecast period, due to the increase in anti-aging products and the increase in revenue.

According to the end user, the longevity market is divided into hospitals and healthcare facilities. Hospitals dominate the market in 2020 and is expected to continue during the forecast period, due to the extensive use of anti-aging products in hospitals for chronic diseases and advancements in technology medicine from AI.

Based on region, North America held the highest market share in terms of revenue in 2020, accounting for more than one-third of the global longevity and anti-senescence therapy market, and is projected to maintain its dominance in terms of revenue by 2030. This is due to surge in demand for anti-aging products, availability of advanced healthcare facilities with trained medical professionals, and presence of key market players. However, Asia-Pacific is projected to portray the fastest CAGR of 6.9% during the forecast period, owing to rise in demand for anti-aging products and availability of advanced healthcare facilities with trained medical professionals.

♦ 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧:
https://www.alliedmarketresearch.com/request-for-customization/14379

Key Findings Of The Study -

♦ Depending on therapy, the gene therapy segment held majority share in the global longevity and anti-senescence therapy market forecast in 2020.
♦ Depending on application, the cancer segment held majority share in the global market in 2020.
♦ According to end user, the hospitals segment held majority share in the global market in 2020.
♦ Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.9% during the forecast period.

✅ 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐈𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 -

Tuberculosis Treatment Drugs Market - https://www.alliedmarketresearch.com/tuberculosis-treatment-drugs-market-A13238

Rehabilitation Equipment Market - https://www.alliedmarketresearch.com/rehabilitation-equipment-market

Leukemia Therapeutics Market - https://www.alliedmarketresearch.com/leukemia-therapeutics-market

Cardiovascular Prosthetic Devices Market - https://www.alliedmarketresearch.com/cardiovascular-prosthetic-devices-market

𝗖𝗼𝗻𝘁𝗮𝗰𝘁:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.